Epigenetic predictive biomarkers for response or outcome to platinum-based chemotherapy in non-small cell lung cancer, current state-of-artWeronika Maria Szejniuk, Oluf Dimitri Røe, Ana I. Robles et al.|The Pharmacogenomics Journal|2018Cited by 61
Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot studyWeronika Maria Szejniuk, Oluf Dimitri Røe, Martin Skovmos Nielsen et al.|Clinical and Translational Radiation Oncology|2019Cited by 10
High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitisWeronika Maria Szejniuk, Oluf Dimitri Røe, Tine McCulloch et al.|Radiation Oncology|2021Cited by 10
Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutationWeronika Maria Szejniuk, Oluf Dimitri Røe, Tine McCulloch|BMJ Case Reports|2014Cited by 4
Elevated mean fractional exhaled nitric oxide and radiation pneumonitis in patients with non-small cell lung cancerWeronika Maria Szejniuk, Oluf Dimitri Røe, Martin Skovmos Nielsen et al.|VBN Forskningsportal (Aalborg Universitet)|2018Cited by 0